Sebastian Bunk is a senior director at Immatics where he leads a team developing a pipeline of bispecific T cell-engaging receptor (TCER®) molecules. After joining Immatics in 2014, Sebastian focused on the establishment of innovative technologies for engineering of T-cell receptors and generation of bispecific TCER® molecules. He is an inventor on >20 patent families in the field of T cell receptor discovery and engineering as well as bispecific TCER®. He obtained his Ph.D. in Biochemical Pharmacology from the University of Konstanz. From 2009 to 2014 he worked in the biotherapeutics division at Baxter Innovations GmbH in Vienna.